Alligator Bioscience AB (FRA:7AL)
€ 0.0445 0.001 (2.3%) Market Cap: 36.64 Mil Enterprise Value: 33.37 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 42/100

Q4 2023 Alligator Bioscience AB Earnings Call Transcript

Feb 09, 2024 / 01:00PM GMT
Release Date Price: €0.0739 (-12.96%)
Greta Eklund
Alligator Bioscience AB - IR & Communications Manager

Welcome to Alligator Bioscience's fourth-quarter and full year 2023 earnings call. I'm Greta Eklund, I'm the Investor Relations and Communications Manager at Alligator, and I will be introducing today's call. With me today are CEO Søren Bregenholt, CFO Marie Svensson, and CMO Sumeet Ambarkhane. They will walk you through the latest developments from the last quarter of 2023 and the upcoming news flow, after which they will be happy to answer any questions you may have.

Before we begin today's call, I would like to share a quick reminder with our listeners that during today's call, management may make forward-looking statements that involve known and unknown risks, uncertainties, and other important factors beyond the company's control that could cause the company's actual results, performance, or achievements to be materially different from the expected results, performance, or achievements expressed or implied by such forward-looking statements. These statements are subject to risks and uncertainties that could cause actual

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot